Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Add-On to Standard Of-Care Study of n Butylphthalide (NBP) Softgel Capsules for Treatment of Mild to Moderate Acute Ischemic Stroke (AIS) in Adult Subjects

NCT02905565 is registered in ClinicalTrials.gov with CSPC-NBP Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02905565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02905565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Add-On to Standard Of-Care Study of n Butylphthalide (NBP) Softgel Capsules for Treatment of Mild to Moderate Acute Ischemic Stroke (AIS) in Adult Subjects
Lead sponsor
CSPC-NBP Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2018
Completion date
August 7, 2020
Enrollment
177 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

ais